Palantir Just $300 Billion: Growth Sparks Mega-Cap Move
Palantir tops $300 billion in market value as Q1 2026 results reveal record growth and expanding margins. The milesto...
What New Crypto Investors Should Know
New crypto investors should know key insights to thrive in the market. Equip yourself with the right information for success.
28,386 articlesHampton Court Hosts Global Energy Drive for Investors
Executives from banking, asset management, and consulting gathered at Hampton Court Palace to launch a private-sector...
Microsoft Stock Analysis: Final Verdict for Investors
This detailed microsoft stock analysis: final verdict breaks down the cloud, AI, and cash flow that power MSFT. Learn...
Blue Chip Dividend Stocks to Buy in June as Dow Turns 130
As the Dow marks its 130th birthday, savvy investors look for steady income and durable growth. Here are three blue c...
QuantumScape Advances Honda Solid-State Pact, Stocks Jump
QuantumScape and Honda announce a multi-year joint R&D pact to accelerate solid-state battery development, sending QS...
Cramer: Cheap Still Cheaper — Salesforce Skeptics Persist
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Adams Wealth Management Trims CLOA Position Amid 2025 Filing
A quarterly filing reveals Adams Wealth Management reduced its holdings in the iShares AAA CLO Active ETF (CLOA). The...
Broadcom Stock Story: The Reason Can’t Stop Buying
Broadcom reports a surge in AI semiconductor revenue and points to a path beyond $100 billion in AI-chip sales by 202...
NVIDIA Just Revealed Meta’s AI Model Boosting Clicks
NVIDIA's earnings call surfaced a link between Meta’s AI model and stronger ad performance, igniting questions for ad...
Apple’s Latest Reveal Proves Micron Has More Room to Run
Apple’s latest reveal proves the memory-cost squeeze is moving from backdrop to driver, signaling pricing power for m...
Earnings Estimates Have Been Climbing Into Q2, Markets Rally
Analysts are revising upward expectations for the Q2 earnings season, driven by energy and technology strength, a rar...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status